Navidea Biopharmaceuticals Inc (NYSE American:NAVB)

0.244
Delayed Data
As of May 25
 -0.0048 / -1.93%
Today’s Change
0.21
Today|||52-Week Range
0.68
-31.94%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Navidea Biopharmaceuticals Inc have a median target of 2.40, with a high estimate of 2.40 and a low estimate of 2.40. The median estimate represents a +883.61% increase from the last price of 0.24.

Analyst Recommendations

There are no recommendations available.

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
--
Sales
-$32.8B
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
 
 
 
 
 
 
Growthannually -86.67%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually 3,142.32%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.